Skip to main content
Fig. 4 | Lipids in Health and Disease

Fig. 4

From: Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study

Fig. 4

Overall survival (OS) and event free survival (EFS) difference based on 9-month IST response. There was a significantly differences on EFS (P = 0.005, A) and OS (P = 0.002, B) between IST-R and IST-NR groups. The estimated 8.5-year EFS was 73.2% and 56.6% in IST-R and IST-NR group, respectively; and the estimated 8.5-year OS was 90.9% and 67.5%, respectively

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X